{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:17:58Z","timestamp":1793578678869,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC-114-2740-B-002-002-"],"award-info":[{"award-number":["NSTC-114-2740-B-002-002-"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2314-B-002-091-MY3"],"award-info":[{"award-number":["110-2314-B-002-091-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"US Cancer Center Grant","award":["CA021765"],"award-info":[{"award-number":["CA021765"]}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"publisher","award":["NTU-CC-109L 104704"],"award-info":[{"award-number":["NTU-CC-109L 104704"]}],"id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["110-L1007"],"award-info":[{"award-number":["110-L1007"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34152-7","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T03:17:38Z","timestamp":1767755858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic landscape of pediatric acute myeloid leukemia in Taiwan"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhongshan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Liang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ti-Cheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hsuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiann-Tarng","family":"Jou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Hsin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Hao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Wei","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Shiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Wen","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phooi-Theng","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Jui","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ling","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Tsamn","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Wha","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hon","family":"Pui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"34152_CR1","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1200\/jco.2015.62.8289","volume":"33","author":"CM Zwaan","year":"2015","unstructured":"Zwaan, C. M. et al. Collaborative efforts driving progress in pediatric acute Myeloid Leukemia. J. Clin. Oncol. 33, 2949\u20132962. https:\/\/doi.org\/10.1200\/jco.2015.62.8289 (2015).","journal-title":"J. Clin. Oncol."},{"key":"34152_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/bjh.12040","volume":"159","author":"JE Rubnitz","year":"2012","unstructured":"Rubnitz, J. E. & Inaba, H. Childhood acute myeloid leukaemia. Br. J. Haematol. 159, 259\u2013276. https:\/\/doi.org\/10.1111\/bjh.12040 (2012).","journal-title":"Br. J. Haematol."},{"key":"34152_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1470-2045(10)70090-5","volume":"11","author":"JE Rubnitz","year":"2010","unstructured":"Rubnitz, J. E. et al. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: Results of the AML02 multicentre trial. Lancet Oncol. 11, 543\u2013552. https:\/\/doi.org\/10.1016\/S1470-2045(10)70090-5 (2010).","journal-title":"Lancet Oncol."},{"key":"34152_CR4","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1182\/blood-2007-04-084293","volume":"111","author":"BJ Lange","year":"2008","unstructured":"Lange, B. J. et al. Outcomes in CCG-2961, a Children\u2019s Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: A report from the Children\u2019s Oncology Group. Blood 111, 1044\u20131053. https:\/\/doi.org\/10.1182\/blood-2007-04-084293 (2008).","journal-title":"Blood"},{"key":"34152_CR5","doi-asserted-by":"publisher","first-page":"e28979","DOI":"10.1002\/pbc.28979","volume":"68","author":"G Egan","year":"2021","unstructured":"Egan, G., Chopra, Y., Mourad, S., Chiang, K. Y. & Hitzler, J. Treatment of acute myeloid leukemia in children: A practical perspective. Pediatr. Blood Cancer 68, e28979. https:\/\/doi.org\/10.1002\/pbc.28979 (2021).","journal-title":"Pediatr. Blood Cancer"},{"key":"34152_CR6","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41375-018-0314-7","volume":"33","author":"AMJ Reedijk","year":"2019","unstructured":"Reedijk, A. M. J. et al. Improved survival for children and young adolescents with acute myeloid leukemia: A Dutch study on incidence, survival and mortality. Leukemia 33, 1349\u20131359. https:\/\/doi.org\/10.1038\/s41375-018-0314-7 (2019).","journal-title":"Leukemia"},{"key":"34152_CR7","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.27625","volume":"100","author":"S Shimony","year":"2025","unstructured":"Shimony, S., Stahl, M. & Stone, R. M. Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and Management. Am. J. Hematol. 100, 860\u2013891. https:\/\/doi.org\/10.1002\/ajh.27625 (2025).","journal-title":"Am. J. Hematol."},{"key":"34152_CR8","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","volume":"361","author":"ER Mardis","year":"2009","unstructured":"Mardis, E. R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 361, 1058\u20131066. https:\/\/doi.org\/10.1056\/NEJMoa0903840 (2009).","journal-title":"N Engl J Med"},{"key":"34152_CR9","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","volume":"363","author":"TJ Ley","year":"2010","unstructured":"Ley, T. J. et al. DNMT3A mutations in acute Myeloid Leukemia. N. Engl. J. Med. 363, 2424\u20132433. https:\/\/doi.org\/10.1056\/NEJMoa1005143 (2010).","journal-title":"N. Engl. J. Med."},{"key":"34152_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature10496","volume":"478","author":"K Yoshida","year":"2011","unstructured":"Yoshida, K. et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478, 64\u201369. https:\/\/doi.org\/10.1038\/nature10496 (2011).","journal-title":"Nature"},{"key":"34152_CR11","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.3324\/haematol.2020.252825","volume":"106","author":"C Chiara","year":"2021","unstructured":"Chiara, C. et al. Clinical significance of chromatin-spliceosome acute myeloid leukemia: A report from the Northern Italy Leukemia Group (NILG) randomized trial 02\/06. Haematologica 106, 2578\u20132587. https:\/\/doi.org\/10.3324\/haematol.2020.252825 (2021).","journal-title":"Haematologica"},{"key":"34152_CR12","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/bloodadvances.2020004173","volume":"5","author":"CA Lachowiez","year":"2021","unstructured":"Lachowiez, C. A. et al. Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax. Blood Adv. 5, 2173\u20132183. https:\/\/doi.org\/10.1182\/bloodadvances.2020004173 (2021).","journal-title":"Blood Adv."},{"key":"34152_CR13","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1182\/blood-2013-07-518746","volume":"123","author":"F Thol","year":"2014","unstructured":"Thol, F. et al. Mutations in the cohesin complex in acute myeloid leukemia: Clinical and prognostic implications. Blood 123, 914\u2013920. https:\/\/doi.org\/10.1182\/blood-2013-07-518746 (2014).","journal-title":"Blood"},{"key":"34152_CR14","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1182\/blood-2014-04-567057","volume":"124","author":"S Thota","year":"2014","unstructured":"Thota, S. et al. Genetic alterations of the cohesin complex genes in myeloid malignancies. Blood 124, 1790\u20131798. https:\/\/doi.org\/10.1182\/blood-2014-04-567057 (2014).","journal-title":"Blood"},{"key":"34152_CR15","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"TJ Ley","year":"2013","unstructured":"Ley, T. J. et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368, 2059\u20132074. https:\/\/doi.org\/10.1056\/NEJMoa1301689 (2013).","journal-title":"N Engl J Med"},{"key":"34152_CR16","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil, E. et al. Genomic classification and prognosis in acute Myeloid Leukemia. N. Engl. J. Med. 374, 2209\u20132221. https:\/\/doi.org\/10.1056\/NEJMoa1516192 (2016).","journal-title":"N. Engl. J. Med."},{"key":"34152_CR17","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner, H. et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140, 1345\u20131377. https:\/\/doi.org\/10.1182\/blood.2022016867 (2022).","journal-title":"Blood"},{"key":"34152_CR18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJMoa2024534","volume":"384","author":"EJ Duncavage","year":"2021","unstructured":"Duncavage, E. J. et al. Genome sequencing as an alternative to cytogenetic analysis in Myeloid cancers. N Engl. J. Med. 384, 924\u2013935. https:\/\/doi.org\/10.1056\/NEJMoa2024534 (2021).","journal-title":"N Engl. J. Med."},{"key":"34152_CR19","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1182\/blood-2012-06-436782","volume":"121","author":"D-C Liang","year":"2013","unstructured":"Liang, D.-C. et al. Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A. Blood 121, 2988\u20132995. https:\/\/doi.org\/10.1182\/blood-2012-06-436782 (2013).","journal-title":"Blood"},{"key":"34152_CR20","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/leu.2011.133","volume":"25","author":"AK Andersson","year":"2011","unstructured":"Andersson, A. K. et al. IDH1 and IDH2 mutations in pediatric acute leukemia. Leukemia 25, 1570\u20131577. https:\/\/doi.org\/10.1038\/leu.2011.133 (2011).","journal-title":"Leukemia"},{"key":"34152_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/leu.2010.307","volume":"25","author":"K Oki","year":"2011","unstructured":"Oki, K. et al. IDH1 and IDH2 mutations are rare in pediatric myeloid malignancies. Leukemia 25, 382\u2013384. https:\/\/doi.org\/10.1038\/leu.2010.307 (2011).","journal-title":"Leukemia"},{"key":"34152_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1365-2141.2011.08879.x","volume":"156","author":"N Shiba","year":"2012","unstructured":"Shiba, N. et al. DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia. Br. J. Haematol. 156, 413\u2013414. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08879.x (2012).","journal-title":"Br. J. Haematol."},{"key":"34152_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nm.4439","volume":"24","author":"H Bolouri","year":"2018","unstructured":"Bolouri, H. et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural Alterations and age-specific mutational interactions. Nat. Med. 24, 103\u2013112. https:\/\/doi.org\/10.1038\/nm.4439 (2018).","journal-title":"Nat. Med."},{"key":"34152_CR24","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1182\/bloodadvances.2019000404","volume":"3","author":"N Shiba","year":"2019","unstructured":"Shiba, N. et al. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia. Blood Adv. 3, 3157\u20133169. https:\/\/doi.org\/10.1182\/bloodadvances.2019000404 (2019).","journal-title":"Blood Adv."},{"key":"34152_CR25","doi-asserted-by":"publisher","unstructured":"Gruber, T. A. et al. An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia. Cancer Cell 22, 683\u2013697, https:\/\/doi.org\/10.1016\/j.ccr.2012.10.007 (2012).","DOI":"10.1016\/j.ccr.2012.10.007"},{"key":"34152_CR26","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.Bcd-21-0160","author":"M Umeda","year":"2022","unstructured":"Umeda, M. et al. Integrated genomic analysis identifies UBTF tandem duplications as a recurrent lesion in pediatric acute myeloid leukemia. Blood Cancer Discov. https:\/\/doi.org\/10.1158\/2643-3230.Bcd-21-0160 (2022).","journal-title":"Blood Cancer Discov."},{"key":"34152_CR27","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.3324\/haematol.2022.281653","volume":"108","author":"EJM Bertrums","year":"2023","unstructured":"Bertrums, E. J. M. et al. Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia. Haematologica 108, 2044\u20132058. https:\/\/doi.org\/10.3324\/haematol.2022.281653 (2023).","journal-title":"Haematologica"},{"key":"34152_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/leu.2016.267","volume":"31","author":"S Struski","year":"2017","unstructured":"Struski, S. et al. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis. Leukemia 31, 565\u2013572. https:\/\/doi.org\/10.1038\/leu.2016.267 (2017).","journal-title":"Leukemia"},{"key":"34152_CR29","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber, D. A. et al. International consensus classification of Myeloid Neoplasms and acute Leukemias: Integrating morphologic, clinical, and genomic data. Blood 140, 1200\u20131228. https:\/\/doi.org\/10.1182\/blood.2022015850 (2022).","journal-title":"Blood"},{"key":"34152_CR30","doi-asserted-by":"publisher","unstructured":"Khoury, J. D. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia 36, 1703\u20131719, https:\/\/doi.org\/10.1038\/s41375-022-01613-1 (2022).","DOI":"10.1038\/s41375-022-01613-1"},{"key":"34152_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41588-023-01640-3","volume":"56","author":"M Umeda","year":"2024","unstructured":"Umeda, M. et al. A new genomic framework to categorize pediatric acute myeloid leukemia. Nat. Genet. 56, 281\u2013293. https:\/\/doi.org\/10.1038\/s41588-023-01640-3 (2024).","journal-title":"Nat. Genet."},{"key":"34152_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219. https:\/\/doi.org\/10.1038\/nbt.2514 (2013).","journal-title":"Nat. Biotechnol."},{"key":"34152_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/bioinformatics\/btr665","volume":"28","author":"DE Larson","year":"2012","unstructured":"Larson, D. E. et al. SomaticSniper: Identification of somatic point mutations in whole genome sequencing data. Bioinformatics 28, 311\u2013317. https:\/\/doi.org\/10.1093\/bioinformatics\/btr665 (2012).","journal-title":"Bioinformatics"},{"key":"34152_CR34","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome. Res. 22, 568\u2013576. https:\/\/doi.org\/10.1101\/gr.129684.111 (2012).","journal-title":"Genome. Res."},{"key":"34152_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13059-016-1029-6","volume":"17","author":"Y Fan","year":"2016","unstructured":"Fan, Y. et al. MuSE: Accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data. Genome. Biol. 17, 178. https:\/\/doi.org\/10.1186\/s13059-016-1029-6 (2016).","journal-title":"Genome. Biol."},{"key":"34152_CR36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. Strelka2: Fast and accurate calling of germline and somatic variants. Nat. Methods 15, 591\u2013594. https:\/\/doi.org\/10.1038\/s41592-018-0051-x (2018).","journal-title":"Nat. Methods"},{"key":"34152_CR37","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/ng.3441","volume":"47","author":"LB Alexandrov","year":"2015","unstructured":"Alexandrov, L. B. et al. Clock-like mutational processes in human somatic cells. Nat. Genet. 47, 1402\u20131407. https:\/\/doi.org\/10.1038\/ng.3441 (2015).","journal-title":"Nat. Genet."},{"key":"34152_CR38","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/ng.3557","volume":"48","author":"J Kim","year":"2016","unstructured":"Kim, J. et al. Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors. Nat. Genet. 48, 600\u2013606. https:\/\/doi.org\/10.1038\/ng.3557 (2016).","journal-title":"Nat. Genet."},{"key":"34152_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421. https:\/\/doi.org\/10.1038\/nature12477 (2013).","journal-title":"Nature"},{"key":"34152_CR40","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1158\/2643-3230.Bcd-21-0010","volume":"2","author":"AM Brandsma","year":"2021","unstructured":"Brandsma, A. M. et al. Mutation signatures of pediatric acute myeloid leukemia and normal blood progenitors associated with differential patient outcomes. Blood Cancer Discov. 2, 484\u2013499. https:\/\/doi.org\/10.1158\/2643-3230.Bcd-21-0010 (2021).","journal-title":"Blood Cancer Discov."},{"key":"34152_CR41","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/s41375-023-01906-z","volume":"37","author":"N Duployez","year":"2023","unstructured":"Duployez, N. et al. UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia. Leukemia 37, 1245\u20131253. https:\/\/doi.org\/10.1038\/s41375-023-01906-z (2023).","journal-title":"Leukemia"},{"key":"34152_CR42","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1182\/blood-2024-198419","volume":"144","author":"B Gibson","year":"2024","unstructured":"Gibson, B. et al. Favourable outcomes in newly diagnosed paediatric AML with Gemtuzumab Ozogamicin and risk-stratified therapy: Results from the International Phase III Myechild 01 Trial. Blood 144, 968. https:\/\/doi.org\/10.1182\/blood-2024-198419 (2024).","journal-title":"Blood"},{"key":"34152_CR43","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1182\/blood.2023021359","volume":"143","author":"JM Barajas","year":"2024","unstructured":"Barajas, J. M. et al. Acute myeloid leukemias with UBTF tandem duplications are sensitive to menin inhibitors. Blood 143, 619\u2013630. https:\/\/doi.org\/10.1182\/blood.2023021359 (2024).","journal-title":"Blood"},{"key":"34152_CR44","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1038\/s41375-024-02368-7","volume":"38","author":"B Cuglievan","year":"2024","unstructured":"Cuglievan, B. et al. Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community. Leukemia 38, 2073\u20132084. https:\/\/doi.org\/10.1038\/s41375-024-02368-7 (2024).","journal-title":"Leukemia"},{"key":"34152_CR45","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","volume":"615","author":"GC Issa","year":"2023","unstructured":"Issa, G. C. et al. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature 615, 920\u2013924. https:\/\/doi.org\/10.1038\/s41586-023-05812-3 (2023).","journal-title":"Nature"},{"key":"34152_CR46","doi-asserted-by":"publisher","first-page":"113084","DOI":"10.1016\/j.celrep.2023.113084","volume":"42","author":"M Neault","year":"2023","unstructured":"Neault, M. et al. CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax. Cell Rep 42, 113084. https:\/\/doi.org\/10.1016\/j.celrep.2023.113084 (2023).","journal-title":"Cell Rep"},{"key":"34152_CR47","doi-asserted-by":"publisher","first-page":"e29221","DOI":"10.1002\/pbc.29221","volume":"68","author":"AK Mishra","year":"2021","unstructured":"Mishra, A. K., Mullanfiroze, K., Chiesa, R. & Vora, A. Azacitidine and venetoclax for post-transplant relapse in a case of CBFA2T3\/GLIS2 childhood acute myeloid leukaemia. Pediatr. Blood Cancer 68, e29221. https:\/\/doi.org\/10.1002\/pbc.29221 (2021).","journal-title":"Pediatr. Blood Cancer"},{"key":"34152_CR48","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1182\/blood.2024026598","volume":"145","author":"G Egan","year":"2025","unstructured":"Egan, G. & Tasian, S. K. Precision medicine for high-risk gene fusions in pediatric AML: A focus on KMT2A, NUP98, and GLIS2 rearrangements. Blood 145, 2574\u20132586. https:\/\/doi.org\/10.1182\/blood.2024026598 (2025).","journal-title":"Blood"},{"key":"34152_CR49","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/ng.3709","volume":"48","author":"ZJ Faber","year":"2016","unstructured":"Faber, Z. J. et al. The genomic landscape of core-binding factor acute myeloid leukemias. Nat. Genet. 48, 1551\u20131556. https:\/\/doi.org\/10.1038\/ng.3709 (2016).","journal-title":"Nat. Genet."},{"key":"34152_CR50","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1182\/bloodadvances.2019000709","volume":"4","author":"Y Ishikawa","year":"2020","unstructured":"Ishikawa, Y. et al. Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11. Blood Adv 4, 66\u201375. https:\/\/doi.org\/10.1182\/bloodadvances.2019000709 (2020).","journal-title":"Blood Adv"},{"key":"34152_CR51","doi-asserted-by":"publisher","first-page":"6050","DOI":"10.1182\/blood-2024-211911","volume":"144","author":"Y Hu","year":"2024","unstructured":"Hu, Y. et al. Outcomes of children and adolescents with acute Myeloid Leukemia and KIT mutations treated with low- or standard-dose chemotherapy plus dasatinib on the CALS\u2162-AML18 trial. Blood 144, 6050\u20136050. https:\/\/doi.org\/10.1182\/blood-2024-211911 (2024).","journal-title":"Blood"},{"key":"34152_CR52","doi-asserted-by":"publisher","first-page":"e30791","DOI":"10.1002\/pbc.30791","volume":"71","author":"S Srinivasan","year":"2024","unstructured":"Srinivasan, S. et al. KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1. Pediatr Blood Cancer 71, e30791. https:\/\/doi.org\/10.1002\/pbc.30791 (2024).","journal-title":"Pediatr Blood Cancer"},{"key":"34152_CR53","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1200\/jco.21.01612","volume":"40","author":"JA Pollard","year":"2022","unstructured":"Pollard, J. A. et al. Sorafenib in combination with standard chemotherapy for children with high allelic ratio FLT3\/ITD+ acute myeloid Leukemia: A report from the children\u2019s oncology group protocol AAML1031. J Clin Oncol 40, 2023\u20132035. https:\/\/doi.org\/10.1200\/jco.21.01612 (2022).","journal-title":"J Clin Oncol"},{"key":"34152_CR54","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/jco.2010.30.7926","volume":"29","author":"VI Gaidzik","year":"2011","unstructured":"Gaidzik, V. I. et al. RUNX1 mutations in acute myeloid Leukemia: Results from a comprehensive genetic and clinical analysis from the AML study group. J. Clin. Oncol. 29, 1364\u20131372. https:\/\/doi.org\/10.1200\/jco.2010.30.7926 (2011).","journal-title":"J. Clin. Oncol."},{"key":"34152_CR55","doi-asserted-by":"publisher","first-page":"5352","DOI":"10.1182\/blood-2009-05-223784","volume":"114","author":"J-L Tang","year":"2009","unstructured":"Tang, J.-L. et al. AML1\/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations. Blood 114, 5352\u20135361. https:\/\/doi.org\/10.1182\/blood-2009-05-223784 (2009).","journal-title":"Blood"},{"key":"34152_CR56","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1182\/blood-2017-11-814442","volume":"131","author":"G Yamato","year":"2018","unstructured":"Yamato, G. et al. RUNX1 mutations in pediatric acute myeloid leukemia are associated with distinct genetic features and an inferior prognosis. Blood 131, 2266\u20132270. https:\/\/doi.org\/10.1182\/blood-2017-11-814442 (2018).","journal-title":"Blood"},{"key":"34152_CR57","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1182\/bloodadvances.2023009814","volume":"7","author":"SD Sisoudiya","year":"2023","unstructured":"Sisoudiya, S. D. et al. Identification of USP9X as a leukemia susceptibility gene. Blood Adv. 7, 4563\u20134575. https:\/\/doi.org\/10.1182\/bloodadvances.2023009814 (2023).","journal-title":"Blood Adv."},{"key":"34152_CR58","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.canlet.2019.03.046","volume":"453","author":"H Akiyama","year":"2019","unstructured":"Akiyama, H. et al. Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress. Cancer Lett. 453, 84\u201394. https:\/\/doi.org\/10.1016\/j.canlet.2019.03.046 (2019).","journal-title":"Cancer Lett."},{"key":"34152_CR59","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.1038\/s41598-021-85321-3","volume":"11","author":"YL Yang","year":"2021","unstructured":"Yang, Y. L. et al. Treatment outcomes of pediatric acute myeloid leukemia: A retrospective analysis from 1996 to 2019 in Taiwan. Sci Rep 11, 5893. https:\/\/doi.org\/10.1038\/s41598-021-85321-3 (2021).","journal-title":"Sci Rep"},{"key":"34152_CR60","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1200\/jco.2011.41.5323","volume":"30","author":"H Inaba","year":"2012","unstructured":"Inaba, H. et al. Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia. J Clin Oncol 30, 3625\u20133632. https:\/\/doi.org\/10.1200\/jco.2011.41.5323 (2012).","journal-title":"J Clin Oncol"},{"key":"34152_CR61","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3324\/haematol.2022.282424","volume":"109","author":"M Maurer-Granofszky","year":"2024","unstructured":"Maurer-Granofszky, M. et al. Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia. Haematologica 109, 740\u2013750. https:\/\/doi.org\/10.3324\/haematol.2022.282424 (2024).","journal-title":"Haematologica"},{"key":"34152_CR62","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/leu.2010.153","volume":"24","author":"VH van der Velden","year":"2010","unstructured":"van der Velden, V. H. et al. Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97\/MRC AML12 protocol. Leukemia 24, 1599\u20131606. https:\/\/doi.org\/10.1038\/leu.2010.153 (2010).","journal-title":"Leukemia"},{"key":"34152_CR63","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/sj.leu.2403979","volume":"20","author":"DC Liang","year":"2006","unstructured":"Liang, D. C. et al. Improved treatment results for childhood acute Myeloid leukemia in Taiwan. Leukemia 20, 136\u2013141. https:\/\/doi.org\/10.1038\/sj.leu.2403979 (2006).","journal-title":"Leukemia"},{"key":"34152_CR64","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3324\/haematol.2010.038976","volume":"96","author":"BV Balgobind","year":"2011","unstructured":"Balgobind, B. V. et al. Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia. Haematologica 96, 1478\u20131487. https:\/\/doi.org\/10.3324\/haematol.2010.038976 (2011).","journal-title":"Haematologica"},{"key":"34152_CR65","doi-asserted-by":"publisher","first-page":"11501","DOI":"10.1038\/s41598-020-68311-9","volume":"10","author":"C-H Yu","year":"2020","unstructured":"Yu, C.-H. et al. MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia. Sci. Rep. 10, 11501. https:\/\/doi.org\/10.1038\/s41598-020-68311-9 (2020).","journal-title":"Sci. Rep."},{"key":"34152_CR66","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/cas.14238","volume":"111","author":"CH Yu","year":"2020","unstructured":"Yu, C. H. et al. TP53 alterations in relapsed childhood acute lymphoblastic leukemia. Cancer Sci 111, 229\u2013238. https:\/\/doi.org\/10.1111\/cas.14238 (2020).","journal-title":"Cancer Sci"},{"key":"34152_CR67","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1182\/blood-2006-03-009233","volume":"108","author":"S Meshinchi","year":"2006","unstructured":"Meshinchi, S. et al. Clinical implications of FLT3 mutations in pediatric AML. Blood 108, 3654\u20133661. https:\/\/doi.org\/10.1182\/blood-2006-03-009233 (2006).","journal-title":"Blood"},{"key":"34152_CR68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635 (2013).","journal-title":"Bioinformatics"},{"key":"34152_CR69","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13059-020-02043-x","volume":"21","author":"L Tian","year":"2020","unstructured":"Tian, L. et al. CICERO: A versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing data. Genome. Biol. 21, 126. https:\/\/doi.org\/10.1186\/s13059-020-02043-x (2020).","journal-title":"Genome. Biol."},{"key":"34152_CR70","doi-asserted-by":"publisher","unstructured":"Nicorici, D. et al. <strong>FusionCatcher<\/strong> \u2013 a tool for finding somatic fusion genes in paired-end RNA-sequencing data. bioRxiv, 011650, https:\/\/doi.org\/10.1101\/011650 (2014).","DOI":"10.1101\/011650"},{"key":"34152_CR71","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13059-018-1421-5","volume":"19","author":"C Ma","year":"2018","unstructured":"Ma, C., Shao, M. & Kingsford, C. SQUID: Transcriptomic structural variation detection from RNA-seq. Genome Biol. 19, 52. https:\/\/doi.org\/10.1186\/s13059-018-1421-5 (2018).","journal-title":"Genome Biol."},{"key":"34152_CR72","doi-asserted-by":"publisher","unstructured":"Melsted, P. et al. Fusion detection and quantification by pseudoalignment. bioRxiv, 166322, https:\/\/doi.org\/10.1101\/166322 (2017).","DOI":"10.1101\/166322"},{"key":"34152_CR73","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13059-019-1842-9","volume":"20","author":"BJ Haas","year":"2019","unstructured":"Haas, B. J. et al. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome Biol. 20, 213. https:\/\/doi.org\/10.1186\/s13059-019-1842-9 (2019).","journal-title":"Genome Biol."},{"key":"34152_CR74","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","volume":"25","author":"K Ye","year":"2009","unstructured":"Ye, K., Schulz, M. H., Long, Q., Apweiler, R. & Ning, Z. Pindel: A pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865\u20132871. https:\/\/doi.org\/10.1093\/bioinformatics\/btp394 (2009).","journal-title":"Bioinformatics"},{"key":"34152_CR75","doi-asserted-by":"publisher","unstructured":"McLeod, C. et al. St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem. Cancer Discov 11, 1082\u20131099, https:\/\/doi.org\/10.1158\/2159-8290.Cd-20-1230 (2021).","DOI":"10.1158\/2159-8290.Cd-20-1230"},{"key":"34152_CR76","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 12, 323. https:\/\/doi.org\/10.1186\/1471-2105-12-323 (2011).","journal-title":"BMC Bioinform."},{"key":"34152_CR77","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol 15, R29. https:\/\/doi.org\/10.1186\/gb-2014-15-2-r29 (2014).","journal-title":"Genome Biol"},{"key":"34152_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4314","author":"E Becht","year":"2018","unstructured":"Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol https:\/\/doi.org\/10.1038\/nbt.4314 (2018).","journal-title":"Nat Biotechnol"},{"key":"34152_CR79","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"34152_CR80","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1200\/JCO.23.02238","volume":"42","author":"TC Chang","year":"2024","unstructured":"Chang, T. C. et al. Genomic determinants of outcome in acute lymphoblastic Leukemia. J. Clin. Oncol. 42, 3491\u20133503. https:\/\/doi.org\/10.1200\/JCO.23.02238 (2024).","journal-title":"J. Clin. Oncol."},{"key":"34152_CR81","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 625, 92\u2013100. https:\/\/doi.org\/10.1038\/s41586-023-06045-0 (2024).","journal-title":"Nature"},{"key":"34152_CR82","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-3-030-91836-1_3","volume":"1361","author":"TC Chang","year":"2022","unstructured":"Chang, T. C., Xu, K., Cheng, Z. & Wu, G. Somatic and germline variant calling from next-generation sequencing data. Adv. Exp. Med. Biol. 1361, 37\u201354. https:\/\/doi.org\/10.1007\/978-3-030-91836-1_3 (2022).","journal-title":"Adv. Exp. Med. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34152-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34152-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34152-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:56:12Z","timestamp":1769680572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34152-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34152"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34152-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Institutional Review Board of National Taiwan University Hospital (REC number: 202207005RINB) approved this study. The parents, guardians, or patients signed the written informed consent in according to the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"4024"}}